OCaP1

N/A

Report date: 2025/03/19 20:00:56

Base Information

Drug NameOCaP1

Drug Alias Nameprostate cancer gene therapy (DirectGene)Ad-OC-E1a

ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adenoviral vector

Mechanisms of ActionUpdating

TargetsUpdating

Therapy Area/IndicationsProstatic Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesAdvagen Inc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesAdvagen Inc

Active IndicationsN/A

Inactive IndicationsProstatic Neoplasms

ATC CodeN/A